INSERM TRANSFERT SA
- Country
- France
- Type
- Beneficiary
- Website
- www.inserm-transfert.fr
- Grants received
- 100
Funding record
- 100 grants on record
- €33,709,323.28 awarded in total
- 2007–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
26 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- KATHOLIEKE UNIVERSITEIT LEUVEN
- MEDIZINISCHE UNIVERSITAET WIEN
- KAROLINSKA INSTITUTET
- ACADEMISCH ZIEKENHUIS LEIDEN
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Calls from this organisation
No published calls from this organisation.
Grants received
- Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS
- A European Proactive Adaptive Clinical Trials Network within EU-Response
- IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research
- Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain
- Assessing and improving access to health and social care SErvices for children RENdered vulnerable by Abuse
- Offering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study.
- Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs
- Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
- Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)
- Fighting childhood obesity to stay healthy all over the life
- Improving treatment efficacy in hypertension by biomarker-guided personalised decision support
- CArdiovascularREsolution of INflammation to promote HEALTH
- Early Interception of Inflammatory-mediated Type 2 Diabetes
- Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytes
- A Coordination and Support Action to prepare UNCAN.eu platform
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.